Orgenesis Inc. Share Price

ORGS

US68619K3032

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 12:25:50 29/08/2026 am IST			5-day change	1st Jan Change
0.1100 ^USD	+236.39%		+10.00%	-26.67%

26/03	Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
26/03	Orgenesis Inc. Auditor Raises 'Going Concern' Doubt	CI

Orgenesis Inc. is a biotech company focused on cell and gene therapies (CGTs). The Company focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. It operates in two segments: Octomera LLC (Octomera segment) and therapies related activities (Therapies segment). The Octomera segment includes mainly point of care (POCare) services. The Therapies segment includes the Companyâ€™s therapeutic development operations. The POCare Services platform is utilized by parties, such as biotech companies and hospitals for the supply of their products. Octomeraâ€™s services include adapting the process to the platform and supplying the products; adaptation of automation and closed systems to serviced therapies, and contract research organization services for clinical trials.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
28/26/28	$0.1100	+236.39%	286
27/26/27	$0.0327	0.00%	2,767
26/26/26	$0.0327	-94.36%	1,100
25/26/25	$0.5800	-1.69%	200
24/26/24	$0.5900	+490.00%	100

Delayed Quote OTC Markets

More quotes

Market Cap	10L 8L 8L 7L 13.66L 9.39Cr 13.7L 94.21L 36.76L 4.74Cr 36.9L 36.1L 16Cr	P/E 2023	-0.26x	P/E 2024	-0.17x
Enterprise Value	1.92Cr 1.65Cr 1.55Cr 1.41Cr 2.66Cr 183.16Cr 2.67Cr 18Cr 7.17Cr 92Cr 7.2Cr 7.04Cr 306.57Cr	EV / Sales 2023	71.2x	EV / Sales 2024	27x
Free-Float	52.06%	Yield 2023 *	-	Yield 2024	-

26/03	Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
26/03	Orgenesis Inc. Auditor Raises 'Going Concern' Doubt	CI
26/03	Okogen, Inc. acquired Global intellectual property portfolio and development assets for ranpirnase from Orgenesis Inc..	CI
14/03	Orgenesis Inc. Announces Board Appointments, Effective March 10, 2026	CI
14/03	Orgenesis Inc. Appoints Doug Karriker as Chief Financial Officer, Effective March 10, 2026	CI
26/25/26	Orgenesis Inc. Announces Resignation of Director Ashish Nanda, Effective August 21, 2025	CI
20/25/20	Orgenesis Inc. Announces Resignation of Victor Miller as Chief Financial Officer	CI
20/25/20	Orgenesis Inc. Announces Executive and Board Changes	CI
06/25/06	Orgenesis Inc. completed the acquisition of Certain assets of Neurocords LLC for $5.7 million.	CI
22/25/22	Orgenesis Inc. announced that it expects to receive $5 million in funding	CI
28/24/28	Orgenesis Inc. Announces Resignation of Jagannathan Bhalaji as A Director	CI
13/24/13	Tranche Update on Orgenesis Inc.'s Equity Buyback Plan announced on May 15, 2020.	CI
13/24/13	Orgenesis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

26/03	Orgenesis : Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)	PU
13/24/13	Orgenesis Provides Third Quarter 2024 Business Update	AQ
21/24/21	Orgenesis Commences Trading on OTCQX® Best Market	AQ
23/24/23	Orgenesis Announces Reverse Stock Split	AQ
29/24/29	Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia	AQ

1 day	+236.39%
1 week	+10.00%
Current month	-84.51%
1 month	-72.50%
3 months	-81.36%
6 months	-63.33%
Current year	-26.67%

1 week	0.03	0.79
1 month	0.02	0.79
Current year	0	0.84
1 year	0	1
3 years	0	10.8
5 years	0	54.3
10 years	0	168

Orgenesis Inc. Share Price

Stocks

ORGS

US68619K3032

Medical Equipment, Supplies & Distribution

Valuation : Orgenesis Inc.

Chart: Orgenesis Inc.

Latest news : Orgenesis Inc.

Press Releases : Orgenesis Inc.

Quotes and Performance

Price Extremes

Managers and Directors : Orgenesis Inc.

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Sarah Ferber CTO	Chief Tech/Sci/R&D Officer	72	02/02/2012
Vered Caplan CEO	Chief Executive Officer	57	24/12/2013
Douglas Karriker DFI	Director of Finance/CFO	51	10/03/2026

Director	Title	Age	Since
Vered Caplan CHM	Chairman	57	14/08/2014
Itzhak Vider BRD	Director/Board Member	64	08/07/2024
Adam Pelavin BRD	Director/Board Member	47	28/10/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
05/03/25	Ariel Malik	Other		12,00,000	23.2142%
12/12/24	Itzhak Vider	Free	Director	1,500	0.0290%
12/12/24	Ashish Nanda	Free	Director	1,835	0.0355%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ORGENESIS INC.	+236.39%	+10.00%	-89.00%	-98.03%	10.78L
ABBOTT LABORATORIES	+0.79%	-3.58%	-14.39%	+9.42%	19TCr
MEDTRONIC PLC	+1.40%	-2.27%	-0.79%	+12.09%	12TCr
CENCORA, INC.	+0.25%	+1.25%	+11.09%	+78.52%	6.15TCr
HOYA CORPORATION	-0.25%	-1.97%	+26.78%	+53.11%	5.1TCr
BECTON, DICKINSON AND COMPANY	+0.74%	-1.29%	-0.90%	-32.69%	5.16TCr
DEXCOM, INC.	+1.71%	-1.65%	+20.96%	-8.53%	3.43TCr
MEDLINE INC.	+1.82%	+2.98%	-	-	3.1TCr
WEST PHARMACEUTICAL SERVICES, INC.	-2.49%	-4.42%	+37.49%	-16.34%	2.37TCr
TERUMO CORPORATION	-0.82%	-1.17%	-4.66%	+18.23%	2.34TCr
Average	+23.95%	-0.99%	-1.49%	+1.75%	5.88TCr
Weighted average by Cap.	+0.67%	-1.86%	+1.09%	+15.87%

	2023	2024
Net sales	5L 5L 4L 4L 7L 5.07Cr 7L 50.8L 19.82L 2.56Cr 19.9L 19.47L 8.48Cr	10.35L 9L 8L 8L 14.38L 9.89Cr 14.43L 99.21L 38.71L 4.99Cr 38.86L 38.01L 17Cr
Net income	-5.54Cr -4.77Cr -4.47Cr -4.08Cr -7.69Cr -529.11Cr -7.72Cr -53Cr -21Cr -267.09Cr -21Cr -20Cr -885.63Cr	-4.82Cr -4.15Cr -3.89Cr -3.55Cr -6.69Cr -460.33Cr -6.71Cr -46Cr -18Cr -232.37Cr -18Cr -18Cr -770.51Cr
Net Debt	2.18Cr 1.88Cr 1.76Cr 1.61Cr 3.03Cr 208.2Cr 3.04Cr 21Cr 8.15Cr 105.1Cr 8.18Cr 8Cr 348.49Cr	1.82Cr 1.57Cr 1.47Cr 1.34Cr 2.53Cr 173.76Cr 2.53Cr 17Cr 6.8Cr 88Cr 6.83Cr 6.68Cr 290.85Cr